2022-08-01 12114233 2023-07-31 12114233 2022-08-01 2023-07-31 12114233 2022-07-31 12114233 2021-08-01 2022-07-31 12114233 uk-core:WithinOneYear 2022-07-31 12114233 uk-core:WithinOneYear 2023-07-31 12114233 uk-core:ShareCapital 2023-07-31 12114233 uk-core:ShareCapital 2022-07-31 12114233 uk-core:RetainedEarningsAccumulatedLosses 2023-07-31 12114233 uk-core:RetainedEarningsAccumulatedLosses 2022-07-31 12114233 uk-bus:Director1 2022-08-01 2023-07-31 12114233 uk-core:AdditionsToInvestments 2023-07-31 12114233 uk-core:AdditionsToInvestments uk-core:Non-currentFinancialInstruments 2023-07-31 12114233 uk-core:CostValuation uk-core:Non-currentFinancialInstruments 2023-07-31 12114233 uk-core:CostValuation 2023-07-31 12114233 uk-core:Non-currentFinancialInstruments 2023-07-31 iso4217:GBP xbrli:pure 12114233 uk-bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 12114233 uk-bus:FRS102 2022-08-01 2023-07-31 12114233 uk-bus:FilletedAccounts 2022-08-01 2023-07-31 12114233 uk-bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31
Sanapharm Limited
Registered Number:12114233
For the year ended 31 July 2023
England and Wales
Unaudited Financial Statements
2
For the year ended 31 July 2023
Sanapharm Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
12114233
As at 31 July 2023
Sanapharm Limited
Statement of Financial Position
£
£
2022
2023
Notes
Fixed assets
Property, plant and equipment
125
250
2
Financial assets
-
1
3
126
250
Current assets
Trade and other receivables
-
286
4
24,941
Cash and cash equivalents
5,598
5,884
24,941
Trade and other payables: amounts falling due within one
year
(16,536)
(5,225)
5
8,405
659
Net current assets
Total assets less current liabilities
785
8,655
785
Net assets
8,655
Capital and reserves
Called up share capital
100
100
Retained earnings
685
8,555
785
8,655
Shareholders' funds
For the year ended 31 July 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006
The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Sana Arif Asmal Director
These financial statements were approved and authorised for issue by the Board on 15 April 2024 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 31 July 2023
Sanapharm Limited
Notes to the Financial Statements
Statutory Information
Sanapharm Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 12114233.
Registered address:
51 Tennis Court Drive
Leicester
LE5 1AS
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
2. Property, plant and equipment
Computer
Equipment
£
Cost or
valuation
At 01 August 2022
500
At 31 July 2023
500
Provision for depreciation and impairment
At 01 August 2022
250
Charge for year
125
At 31 July 2023
375
At 31 July 2023
Net book value
125
At 31 July 2022
250
2 of 3
5
For the year ended 31 July 2023
Sanapharm Limited
Notes to the Financial Statements Continued
3. Investments held as fixed assets
Other investments
Total
Cost
£
£
1
1
Additions
At 31 July 2023
1
1
At 31 July 2023
Net book value
1
1
4. Trade and other receivables
2022
2023
£
£
Other debtors
286
-
5. Trade and other payables: amounts falling due within one year
2022
2023
£
£
Taxation and social security
-
2,277
Other creditors
5,225
14,259
5,225
16,536
6. Average number of persons employed
During the year the average number of employees was 1 (2022 : 2)
3 of 3